Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective

Respir Investig. 2018 Sep;56(5):375-383. doi: 10.1016/j.resinv.2018.06.002. Epub 2018 Jul 27.

Abstract

Epidemiologic data suggest that there are ethnic differences between Japanese and other populations with regard to the important clinical aspects of interstitial lung disease (ILD), such as the cause of death and prognostic factors in patients with idiopathic pulmonary fibrosis (IPF). Acute exacerbation (AE) of IPF may be more common in Japan than in the rest of the world, although this suggestion remains controversial. Moreover, AE of ILD induced by gefitinib may also be more common in Japan, indicating that Japanese patients have a genetic vulnerability or susceptibility to AE. Recent large-scale studies are starting to reveal ethnic differences in the genetics of ILD, including the prevalence of the genetic polymorphisms associated with the clinical course of ILD. We anticipate that ongoing and upcoming research regarding ethnic differences will continue to provide valuable insights into the pathogenesis and management of ILD.

Keywords: Acute exacerbation; Ethnic differences; Idiopathic pulmonary fibrosis; Japanese.

Publication types

  • Review

MeSH terms

  • Asian People / genetics
  • Cause of Death
  • Disease Progression
  • Female
  • Gefitinib
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Idiopathic Pulmonary Fibrosis / complications
  • Idiopathic Pulmonary Fibrosis / ethnology*
  • Idiopathic Pulmonary Fibrosis / genetics*
  • Idiopathic Pulmonary Fibrosis / mortality
  • Japan / epidemiology
  • Japan / ethnology
  • Lung Neoplasms / complications
  • Lung Neoplasms / therapy
  • Male
  • Pneumonectomy
  • Prevalence
  • Prognosis
  • Protein Kinase Inhibitors / adverse effects
  • Quinazolines / adverse effects
  • Sex Factors
  • Survival Rate

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Gefitinib